Endocrinology and metabolism Archives - Page 6 of 6

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the treatment of type 2 diabetes mellitus from a UK Healthcare system perspective

Authors: M Charokopou, P McEwan, S Listers, L Callan, K Bergenheim, K Tolley, R Postema, R Townsend, M Roudaut Published: BMC Health Services Research, 2015 View publication Background Type 2 diabetes mellitus...

Economic impact of using fesoterodine for the treatment of overactive bladder with urge urinary incontinence in a vulnerable elderly population in the United States.

Authors: L Qin, X Luo, K H Zou, S J Snedecor Published: Journal of Medical Economics, 2016 View publication Objective To assess the costs of treating overactive bladder (OAB) with fesoterodine compared...

Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: an analysis based on a large sample of 456,586 German T2DM patients

Authors: T Wilke, B Boettger, B Berg, A Groth, S Mueller, M Botteman, S Yu, A Fuchs, U Maywald Published: Journal of Diabetes Complications, 2015 View publication Introduction This analysis was conducted...

Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: a systematic review of the literature from 2008 to 2013

Authors: M Charokopou, F J Sabater, R Townsend, M Roudaut, P McEwan, B G Verheggen Published: Current Medical Research and Opinion, 2016 View publication Objective To identify and compare health-economic models that...

Making economic evaluations more helpful for treatment choices in haemophilia

Authors: M Drummond, N Houwing, U Slothuus, P Giangrande Published: Haemophilia : the official journal of the World Federation of Hemophilia, 2017 View publication Aim Poorly conducted economic evaluations have the potential...

News